Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The FDA denied all 22 CPs the same day they issued a CRL to Amarin in 2015. The CP they denied yesterday was due to a technicality (they went so far as to provide instructions how to submit patent disputes correctly in the rejection letter). There are two remaining CPs, one of which is related to the sNDA.